Clinical Trial Update: A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea. [Phase 2]

View source ↗

Summary

A Phase II randomized trial evaluating ACZONE Gel 5% (dapsone) for papulopustular rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• ACZONE Gel 5% (Dapsone)

Snippet

Sponsor: Allergan | Conditions: Rosacea | Phase 2 | Status: COMPLETED